Status:
COMPLETED
Bone Mineral Density, Disease Duration, and Activity in Ankylosing Spondylitis
Lead Sponsor:
Bezmialem Vakif University
Conditions:
Ankylosing Spondylitis
Osteoporosis
Eligibility:
All Genders
18-65 years
Brief Summary
Our clinical study aimed to evaluate the prevalence of osteoporosis (OP) in patients with ankylosing spondylitis (AS) and to investigate the relationship between clinical, disease activity, physical f...
Detailed Description
In this cross-sectional study, patients who were admitted to the rheumatology clinic between 18 and 65 years of age and diagnosed as AS according to the modified New York diagnostic criteria were incl...
Eligibility Criteria
Inclusion
- Patients diagnosed as AS according to the modified New York diagnostic criteria were included
Exclusion
- Patients previously diagnosed with OP,
- Patients previously treated with OP,
- Patients with bone fractures previously associated with OP,
- Those using drugs that affect bone metabolism, metabolic bone diseases (Paget's -disease, osteomalacia, hyperparathyroidism),
- Diabetes mellitus,
- Hypothyroidism, hyperthyroidism,
- Patients with kidney, liver and intestinal diseases,
- Those using corticosteroids
Key Trial Info
Start Date :
July 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2019
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT03866135
Start Date
July 1 2018
End Date
January 31 2019
Last Update
March 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bezmialem Vakif University
Istanbul, Fatih, Turkey (Türkiye), 34093